Binocular Diabetic Retinopathy Severity Scale

INDIANAPOLIS — APX3330, an investigational oral treatment for diabetic retinopathy, reduced the development of proliferative diabetic retinopathy vs. placebo among high-risk patients, according to a poster presented at Academy 2024.